Belviq is an FDA-approved prescription brand name weight loss medication manufactured by Arena Pharmaceuticals. This drug suppresses the appetite and can help a person feel fuller for longer and may make it easier for an individual to adopt and stick to a healthy, calorie-conscious diet.
This product contains lorcaserin, a drug that works by controlling a person’s appetite. It manages to help curb a person’s hunger by activating a neurotransmitter called serotonin, which triggers feelings of fullness and satisfaction. Primarily, Belviq is prescribed alongside diet and exercise for the treatment of obesity (a body mass index (BMI) of 30 or higher). It may also be prescribed to treat individuals who are overweight (a BMI of 27 or higher) or who have at least one weight-related health condition, such as high blood pressure, high cholesterol and diabetes.
In terms of its effectiveness, clinical trial data submitted by Arena to the FDA shows that almost half of dieters in the trial, who didn’t have Type 2 diabetes and who used the medication, lost a minimum of 5 percent of their starting weight (an approximate average of 12 pounds) over one year, compared to 23 percent of individuals taking a placebo. While this study does prove that weight loss is possible when taking Belviq, losing only 12 pounds in one year doesn’t seem overly impressive for a fat loss medication that is also linked to some rather unpleasant side effects.
In some users, Belviq can cause certain adverse effects, such as dizziness, fatigue, nausea, headaches, dry mouth and constipation. In addition, individuals who have diabetes may experience side effects like cough, fatigue, headache, back pain and low blood sugar. Due to this fact, some patients may need to have their blood sugar closely monitored when taking this medication.
Belviq is not safe for everyone. Anyone who is allergic to lorcaserin or who is pregnant should not take this medication. Furthermore, individuals who have diabetes, a heart valve disorder, congestive heart failure, leukemia, myeloma, sickle cell anemia, kidney or liver disease, or a physical deformity of the penis (ex. Peyronie’s disease) should inform their doctor of their condition.
That being said, prior to taking Belviq, any health condition (past or present) should be reported to your doctor, as well as any medication (prescription, over-the-counter, supplements) you may currently be taking, as Belviq can interact with several medications.
Finally, Belviq is a short-term treatment for weight loss. Prolonged use of this drug can be habit forming.